IP Library Granted Patent US 11,198,853
Granted Patent B2
US 11,198,853 · App. 16/295,423 · Granted Dec 14, 2021

Engineered glucosyltransferases

Inventors: Yougen Li (Pennington, NJ); Ellen D. Semke (Newark, DE)
Assignee: NUTRITION & BIOSCIENCES USA 4, INC.
C12N9/1051C12P19/04C12P19/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,198,853
App. No.
16/295,423
Granted
Dec 14, 2021
Kind
B2
Abstract

Disclosed herein are glucosyltransferases with modified amino acid sequences. Such engineered enzymes synthesize insoluble alpha-glucan products having decreased molecular weight. Further disclosed are reactions and methods in which engineered glucosyltransferases are used to produce insoluble alpha-glucan.

Claims (44)

1. A non-native glucosyltransferase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:66, wherein said amino acid sequence has at least one amino acid substitution at a position corresponding with amino acid residue Leu-282, Pro-319, Ser-322, Asn-326, Asn-327, Trp-340, Asn-342, Asp-344, Lys-347, Asn-350, Thr-354, or Gln-385 of SEQ ID NO:66,

wherein the non-native glucosyltransferase uses sucrose to synthesize insoluble alpha-glucan comprising at least 50% alpha-1,3-glycosidic linkages, and the molecular weight of said insoluble alpha-glucan is at least 10% lower than the molecular weight of insoluble alpha-glucan synthesized by a second glucosyltransferase that only differs from the non-native glucosyltransferase at the substitution position(s).

2. The non-native glucosyltransferase of claim 1 , comprising at least one amino acid substitution at a position corresponding with amino acid residue Leu-282, Ser-322, Asn-342, Asp-344, Lys-347, or Gln-385 of SEQ ID NO:66.

3. The non-native glucosyltransferase of claim 1 , wherein:

(i) the amino acid substitution at the position corresponding with amino acid residue Leu-282 is with an Ala, Cys, Asp, Glu, Phe, Gly, His, Ile, Lys, Met, Asn, Pro, Gln, Arg, Ser, Thr, Val, Trp, or Tyr residue;

(ii) the amino acid substitution at the position corresponding with amino acid residue Pro-319 is with a Leu, Val, or Ile residue;

(iii) the amino acid substitution at the position corresponding with amino acid residue Ser-322 is with an Ala, Cys, Glu, Phe, His, Ile, Met, Asn, Arg, Thr, Val, or Tyr residue;

(iv) the amino acid substitution at the position corresponding with amino acid residue Asn-326 is with a Glu, Gln, Ile, Thr, Asp, Asn, Leu, Val, or Ser residue;

(v) the amino acid substitution at the position corresponding with amino acid residue Asn-327 is with an Asp or Glu residue;

(vi) the amino acid substitution at the position corresponding with amino acid residue Trp-340 is with a Val, Asp, Cys, Ile, Leu, Glu, or Ser residue;

(vii) the amino acid substitution at the position corresponding with amino acid residue Asn-342 is with an Ala, Asp, Gly, His, Ile, Lys, Leu, Met, Asn, Pro, Thr, Val, or Trp residue;

(viii) the amino acid substitution at the position corresponding with amino acid residue Asp-344 is with an Ala, Cys, Glu, Phe, Gly, His, Ile, Lys, Leu, Met, Asn, Pro, Arg, Ser, Val, Trp, or Tyr residue;

(ix) the amino acid substitution at the position corresponding with amino acid residue Lys-347 is with an Ala, Cys, Asp, Glu, Phe, Gly, His, Ile, Leu, Met, Asn, Pro, Gln, Arg, Ser, Thr, Val, Trp, or Tyr residue;

(x) the amino acid substitution at the position corresponding with amino acid residue Asn-350 is with a Pro or Gly residue;

(xi) the amino acid substitution at the position corresponding with amino acid residue Thr-354 is with a Pro or Gly residue; and/or

(xii) the amino acid substitution at the position corresponding with amino acid residue Gln-385 is with an Ala, Cys, Asp, Glu, Gly, His, Ile, Lys, Leu, Met, Asn, Pro, Arg, Ser, Thr, Val, Trp, or Tyr residue.

4. The non-native glucosyltransferase of claim 1 , comprising at least one amino acid substitution at a position corresponding with amino acid residue Pro-319, Asn-326, Asn-327, Asn-350, or Thr-354 of SEQ ID NO:66.

5. The non-native glucosyltransferase of claim 1 , wherein the insoluble alpha-glucan comprises at least about 80% alpha-1,3 glycosidic linkages.

6. The non-native glucosyltransferase of claim 5 , wherein the insoluble alpha-glucan comprises at least about 90% alpha-1,3 glycosidic linkages.

7. The non-native glucosyltransferase of claim 1 , wherein the insoluble alpha-glucan has a weight average degree of polymerization (DPw) of less than about 300.

8. The non-native glucosyltransferase of claim 7 , wherein the insoluble alpha-glucan has a DPw of less than about 150.

9. The non-native glucosyltransferase of claim 8 , wherein the insoluble alpha-glucan has a DPw of less than about 75.

10. The non-native glucosyltransferase of claim 1 , wherein the molecular weight of said insoluble alpha-glucan is at least 25% lower than the molecular weight of insoluble alpha-glucan synthesized by said second glucosyltransferase.

11. A reaction composition comprising water, sucrose, and a non-native glucosyltransferase according to claim 1 .

12. A method of producing insoluble alpha-glucan comprising 1,3-glycosidic linkages, the method comprising:

contacting at least water, sucrose, and a non-native glucosyltransferase enzyme according to claim 1 , whereby insoluble alpha-glucan comprising 1,3-glycosidic linkages is produced.

13. The method of claim 12 , further comprising a step of isolating the insoluble alpha-glucan.

14. The method of claim 12 , wherein the insoluble alpha-glucan comprises at least about 80% alpha-1,3 glycosidic linkages.

15. The method of claim 12 , wherein the insoluble alpha-glucan has a weight average degree of polymerization (DPw) of less than about 300.

16. The method of claim 12 , wherein the non-native glucosyltransferase comprises an amino acid sequence that is at least about 95% identical to SEQ ID NO:66.

17. The non-native glucosyltransferase of claim 2 , wherein:

(i) the amino acid substitution at the position corresponding with amino acid residue Leu-282 is with an Ala, Cys, Asp, Glu, Phe, Gly, His, Ile, Lys, Met, Asn, Pro, Gln, Arg, Ser, Thr, Val, Trp, or Tyr residue;

(ii) the amino acid substitution at the position corresponding with amino acid residue Ser-322 is with an Ala, Cys, Glu, Phe, His, Ile, Met, Asn, Arg, Thr, Val, or Tyr residue;

(iii) the amino acid substitution at the position corresponding with amino acid residue Asn-342 is with an Ala, Asp, Gly, His, Ile, Lys, Leu, Met, Asn, Pro, Thr, Val, or Trp residue;

(iv) the amino acid substitution at the position corresponding with amino acid residue Asp-344 is with an Ala, Cys, Glu, Phe, Gly, His, Ile, Lys, Leu, Met, Asn, Pro, Arg, Ser, Val, Trp, or Tyr residue;

(v) the amino acid substitution at the position corresponding with amino acid residue Lys-347 is with an Ala, Cys, Asp, Glu, Phe, Gly, His, Ile, Leu, Met, Asn, Pro, Gln, Arg, Ser, Thr, Val, Trp, or Tyr residue; and/or

(vi) the amino acid substitution at the position corresponding with amino acid residue Gln-385 is with an Ala, Cys, Asp, Glu, Gly, His, Ile, Lys, Leu, Met, Asn, Pro, Arg, Ser, Thr, Val, Trp, or Tyr residue.

18. The non-native glucosyltransferase of claim 4 , wherein:

(i) the amino acid substitution at the position corresponding with amino acid residue Pro-319 is with a Leu, Val, or Ile residue;

(ii) the amino acid substitution at the position corresponding with amino acid residue Asn-326 is with a Glu, Gln, Ile, Thr, Asp, Asn, Leu, Val, or Ser residue;

(iii) the amino acid substitution at the position corresponding with amino acid residue Asn-327 is with an Asp or Glu residue;

(iv) the amino acid substitution at the position corresponding with amino acid residue Asn-350 is with a Pro or Gly residue; and/or

(v) the amino acid substitution at the position corresponding with amino acid residue Thr-354 is with a Pro or Gly residue.

19. The non-native glucosyltransferase of claim 1 , wherein the non-native glucosyltransferase comprises an amino acid sequence that is at least about 95% identical to SEQ ID NO:66.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2020
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: NUTRITION & BIOSCIENCES USA 4, INC.
Reel/Frame 055028/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENTITY FOR ASSIGNEE PREVIOUSLY RECORDED AT REEL: 49879 FRAME: 212. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 6, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 050301/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 049879/0212 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2019
From: LI, YOUGEN; SEMKE, ELLEN D.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 049195/0283 →
Cited By (1)
US 12,618,051